Jump to content

User:P. Oncology/Prostate cancer screening

From Wikipedia, the free encyclopedia

Article Draft

[edit]

Lead

[edit]

Article body

[edit]

Revising This:

Prostate biopsies are considered the gold standard in detecting prostate cancer. Infection is a possible risk. MRI guided techniques have improved the diagnostic accuracy of the procedure. Biopsies can be done through the rectum or penis.

Revisions:

The biopsy technique includes factors such as needle angle and prostate mapping method. [1] Patients with localized cancer and perineurial invasion may benefit more from immediate treatment rather than adopting a watchful waiting approach.[1]

Psychological Impact of Screening

[edit]

Men report low levels of distress surrounding PSA screening[2]. Men who present for PSA or have PSA levels at baseline scored low on cancer distress on numerous scales.[2]

References

[edit]
  1. Harnden, P., Shelley, M. D., Clements, H., Coles, B., Tyndale-Biscoe, R. S., Naylor, B., & Mason, M. D. (2007). The prognostic significance of perineural invasion in prostatic cancer biopsies: A systematic review. Cancer, 109(1), 13–24. https://doi.org/10.1002/cncr.22388
  1. ^ a b Harnden, Patricia; Shelley, Michael D.; Clements, Hayley; Coles, Bernadette; Tyndale‐Biscoe, R. Sandy; Naylor, Brian; Mason, Malcolm D. (2007-01). "The prognostic significance of perineural invasion in prostatic cancer biopsies: A systematic review". Cancer. 109 (1): 13–24. doi:10.1002/cncr.22388. ISSN 0008-543X. {{cite journal}}: Check date values in: |date= (help)
  2. ^ a b Chad‐Friedman, Emma; Coleman, Sarah; Traeger, Lara N.; Pirl, William F.; Goldman, Roberta; Atlas, Steven J.; Park, Elyse R. (2017-10-15). "Psychological distress associated with cancer screening: A systematic review". Cancer. 123 (20): 3882–3894. doi:10.1002/cncr.30904. ISSN 0008-543X. PMC 8116666. PMID 28833054.{{cite journal}}: CS1 maint: PMC format (link)